Publications by authors named "J Gaillat"

Claim this Profile
R
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 Season.
Hélène Bricout, Marie-Cécile Levant, Pascal Crépey, Gaëtan Gavazzi, Jacques Gaillat

Influenza Other Respir Viruses· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention and monitoring of pertussis].
Nicole Guiso, Jacques Gaillat

Rev Prat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients" [Heliyon Volume 10, Issue 13, July 15, 2024, Article e33231].
Quentin Philippot, Blandine Rammaert, Gaëlle Dauriat, Cédric Daubin, Frédéric Schlemmer, Jacques Gaillat

Heliyon· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement and comparative accuracy of instability criteria at discharge for predicting adverse events in patients with community-acquired pneumonia.
Anne Danjou, Magali Bouisse, Bastien Boussat, Sophie Blaise, Jacques Gaillat

BMJ Open Respir Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.
F P Alvarez, L Allard, F Bianic, H Bricout, P Crépey, J Gaillat

J Med Econ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis